Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZRSR2 pseudogene 1 (ZRSR2P1) is a noncoding pseudogene in humans, derived from retrotransposition of the functional ZRSR2 gene, and does not encode a functional protein[1][4][5]. In humans, ZRSR2P1 is designated as a pseudogene and does not appear to be expressed at notable levels or to have biological activity. Functional splicing activity related to U12-type introns is carried out by the canonical ZRSR2 protein and, in some species (such as mouse), by a functional retrocopy Zrsr1[1]. In contrast, the human ZRSR2P1 does not contribute to splicing and is widely considered nonfunctional. It is not regarded as a therapeutic target and has no known disease association or drug interactions. Key clarifications: This entity is a pseudogene (non-functional gene); in human tissues, it produces neither protein nor biological activity[1][4][5]. The functional gene is ZRSR2, which is essential for minor (U12-type) spliceosome function. In mice, Zrsr1 (the homologous retrogene) can be functional, but this does not apply to human ZRSR2P1[1]. No drugs, disease associations, or biomarker roles are known for ZRSR2P1. Summary: ZRSR2 pseudogene 1 (ZRSR2P1) is a non-functional, non-coding pseudogene in humans and should not be considered a drug target or functional gene. Its nomenclature frequently overlaps with other functional spliceosomal proteins, causing confusion, but the human ZRSR2P1 does not encode a protein or participate in mRNA processing[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZRSR2 pseudogene 1 (ZRSR2P1).